Head of GI Cancers, Global Marketing, Oncology Business Unit

Role Summary

Head of GI Cancers, Global Marketing, Oncology Business Unit. As a member of Takeda Oncology, contribute to an inspiring vision to cure cancer. Part of the Global Oncology Products & Pipeline Strategy team, reporting to the Head of Global Oncology Products, Pipeline and Strategy and collaborating with a cross-functional, global team to drive an asset in the GI cancer space. Location: Boston, MA.

Responsibilities

• Shape and influence global asset strategy through deep collaboration with R&D and Global Product Leaders, driving the development of the Clinical Development Program (CDP) and other critical asset components.
• Partner with senior leadership across functions, including the Global Product Team, to accelerate asset development and deliver on KPI’s & revenue targets.
• Lead execution of the global asset strategy, ensuring commercial launch readiness and alignment with Takeda Oncology’s overarching business objectives.
• Drive development of the GI Disease Area Strategy and Brand Plan, including branding elements, financial planning, forecasting, and life cycle management to maximize portfolio value.
• Inspire and lead a high-performing team of Global Brand and CDx Leads, fostering strategic excellence and flawless execution to achieve brand success and competitive differentiation.
• Set the strategic commercial direction for the GI oncology asset, driving portfolio optimization through validated growth opportunities, life cycle management (LCM), and prioritized initiatives.
• Own enterprise-level launch readiness, ensuring governance alignment and flawless execution of pre-launch and launch activities.
• Lead insight-driven decision-making, converting market intelligence into a compelling brand narrative; leverage analytics to validate opportunities, optimize marketing mix, and maximize ROI on brand investments.
• Shape managed markets strategy to secure long-term brand value, partnering across internal and external stakeholders to deliver pricing, access, and reimbursement solutions.
• Drive LCM strategy to expand indications and sustain competitive advantage, proactively anticipating market dynamics and orchestrating cross-functional execution to maximize asset value.

Qualifications

• Required: Bachelor’s degree with 10+ years of progressive pharmaceutical experience in marketing, or strategy, including exposure to both U.S. and ex-U.S. markets.
• Required: Proven oncology expertise, including in new product planning, and successful launch execution.
• Required: Deep oncology knowledge, market dynamics, brand/franchise management, and effective HCP engagement strategies.
• Required: 3–5+ years of leadership experience, with a track record of managing and developing high-performing teams.
• Required: Demonstrated P&L ownership and strong financial acumen, including forecasting and resource allocation.
• Required: Extensive experience in marketing strategy and execution, with the ability to communicate vision and influence internal stakeholders and external agencies.
• Required: Strong collaboration skills, partnering effectively across countries, functions, and senior leadership to drive asset development and revenue growth.
• Required: Proven ability to manage complexity and lead through change, demonstrating learning agility and adaptability.
• Required: Strategic decision-making capability, balancing business, financial, and risk considerations to deliver optimal outcomes.
• Required: Influential leadership, including situations without direct authority, to align stakeholders and drive results.
• Preferred: MBA and/or PhD
• Preferred: Experience in GI Cancers